Skip to main content
SpringerLink
Log in

Hepatic Coagulopathy: Intricacies and Challenges

  • Chapter
  • First Online:
Hematopathology

  • 1270 Accesses

Abstract

Liver is an elegant factory which synthesizes several plasma proteins, transport proteins, and most of the clotting factors to name just a few of its immense synthetic function. Virtually every arm of the complex hemostatic pathway gets deranged in liver disease. Hence, it is quite natural to find abnormal tests of hemostasis in patients with chronic liver disease (CLD). A bleeding as well as a clotting tendency does exist simultaneously in liver disease. These are due to a set of complex and multifactorial process leading to a state of rebalanced hemostasis in stable cirrhosis patients [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Caldwell SH. Management of coagulopathy in liver disease. Gastroenterol Hepatol (N Y). 2014;10(5):330–2.

    Google Scholar 

  2. Sharara AI, Rockey DC. Gastroesophageal variceal hemorrhage. N Engl J Med. 2001;345(9):669–81.

    Article  CAS  Google Scholar 

  3. Tripodi A, Mannucci PM. Abnormalities of hemostasis in chronic liver disease: reappraisal of their clinical significance and need for clinical and laboratory research. J Hepatol. 2007;46:727–33.

    Article  CAS  Google Scholar 

  4. Afdhal N, McHutchison J, Brown R, Jacobson I, Manns M, Poordad F, Weksler B, Esteban R. Thrombocytopenia associated with chronic liver disease. J Hepatol. 2008;48(6):1000–7.

    Article  CAS  Google Scholar 

  5. Hugenholtz GG, Porte RJ, Lisman T. The platelet and platelet function testing in liver disease. Clin Liver Dis. 2009;13(1):11–20.

    Article  Google Scholar 

  6. Trotter JF. Coagulation abnormalities in patients who have liver disease. Clin Liver Dis. 2006;10:665–78.

    Article  Google Scholar 

  7. Hollestelle MJ, Thinnes T, Crain K, Stiko A, Kruijt JK, van Berkel TJ, et al. Tissue distribution of factor VIII gene expression in vivo—a closer look. Thromb Haemost. 2001;86:855–61.

    Article  CAS  Google Scholar 

  8. Ben-Ari Z, Osman E, Hutton RA, et al. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction? Am J Gastroenterol. 1999;94:2977–82.

    Article  CAS  Google Scholar 

  9. Ng VL. Liver disease, coagulation testing, and hemostasis. Clin Lab Med. 2009;29:265–82.

    Article  Google Scholar 

  10. Lisman T, Leebeek FWG, de Groot PG. Haemostatic abnormalities in patients with liver disease. J Hepatol. 2002;37:280–7.

    Article  CAS  Google Scholar 

  11. Amitrano L, Brancaccio V, Guardascione MA, Margaglione M, Iannaccone L, D’Andrea G, et al. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology. 2000;31:345–8.

    Article  CAS  Google Scholar 

  12. Tripodi A. Tests of coagulation in liver disease. Clin Liver Dis. 2009;13:55–61.

    Article  Google Scholar 

  13. Lisman T, Leebeek FW, Mosnier LO, et al. Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis. Gastroenterology. 2001;121:131–9.

    Article  CAS  Google Scholar 

  14. Colucci M, Binetti BM, Branca MG, et al. Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis. Hepatology. 2003;38:230–7.

    Article  CAS  Google Scholar 

  15. Smalberg JH, Leebeek FWG. Superimposed coagulopathic conditions in cirrhosis: infection and endogenous heparinoids, renal failure, and endothelial dysfunction. Clin Liver Dis. 2009;13:33–42.

    Article  Google Scholar 

  16. Violi F, Leo R, Vezza E, et al. Bleeding time in patients with cirrhosis: relation with degree of liver failure and clotting abnormalities. C.A.L.C. Group. Coagulation Abnormalities in Cirrhosis Study Group. J Hepatol. 1994;20(4):531–6.

    Article  CAS  Google Scholar 

  17. Boberg KM, Brosstad F, Egeland T, Egge T, Schrumpf E. Is a prolonged bleeding time associated with an increased risk of hemorrhage after liver biopsy? Thromb Haemost. 1999;81:378–81.

    Article  CAS  Google Scholar 

  18. Cattaneo M, Tenconi PM, Alberca I, et al. Subcutaneous desmopressin (DDAVP) shortens the prolonged bleeding time in patients with liver cirrhosis. Thromb Haemost. 1990;64(3):358–60.

    Article  CAS  Google Scholar 

  19. de Franchis R, Arcidiacono PG, Carpinelli L, et al. Randomized controlled trial of desmopressin plus terlipressin vs. terlipressin alone for the treatment of acute variceal hemorrhage in cirrhotic patients: a multicenter, double-blind study. New Italian Endoscopic Club. Hepatology. 1993;18(5):1102–7.

    Article  Google Scholar 

  20. Wong AY, Irwin MG, Hui TW, et al. Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. Can J Anaesth. 2003;50(1):14–20.

    Article  Google Scholar 

  21. Lisman T, Bongers TN, Adelmeijer J, Janssen HL, de Maat MP, de Groot PG, et al. Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology. 2006;44:53–61.

    Article  CAS  Google Scholar 

  22. McVay PA, Toy PT. Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities. Am J Clin Pathol. 1990;94:747–53.

    Article  CAS  Google Scholar 

  23. Cobb WS, Heniford BT, Burns JM, Carbonell AM, Matthews BD, Kercher KW. Cirrhosis is not a contraindication to laparoscopic surgery. Surg Endosc. 2005;19:418–23.

    Article  CAS  Google Scholar 

  24. Inabnet WB, Deziel DJ. Laparoscopic liver biopsy in patients with coagulopathy, portal hypertension, and ascites. Am Surg. 1995;61:603–6.

    CAS  PubMed  Google Scholar 

  25. Ewe K. Bleeding after liver biopsy does not correlate with indices of peripheral coagulation. Dig Dis Sci. 1981;26:388–93.

    Article  CAS  Google Scholar 

  26. Segal JB, Dzik WH. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion. 2005;45:1413–25.

    Article  Google Scholar 

  27. Huntington JA. Mechanisms of glycosaminoglycan activation of the serpins in hemostasis. J Thromb Haemost. 2003;1:1535–49.

    Article  CAS  Google Scholar 

  28. Kovacs MH, Wong A, MacKinnon K, et al. Assessment of the validity of the INR system for patients with liver impairment. Thromb Haemost. 1994;71:727–30.

    Article  CAS  Google Scholar 

  29. Denson KWE, Reed SV, Haddon ME, et al. Comparative studies of rabbit and human recombinant tissue factor reagents. Thromb Res. 1999;94:255–61.

    Article  CAS  Google Scholar 

  30. Kar R, Kar SS, Sarin SK. Hepatic coagulopathy-intricacies and challenges; a cross-sectional descriptive study of 110 patients from a superspecialty institute in North India with review of literature. Blood Coagul Fibrinolysis. 2013;24(2):175–80.

    Article  Google Scholar 

  31. Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor liver. Gastroenterology. 2003;124:91–6.

    Article  Google Scholar 

  32. Hemker HC, Giesen P, Al Dieri R, et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb. 2003;33:4–15.

    Article  CAS  Google Scholar 

  33. Tripodi A, Salerno F, Chantarangkul V, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology. 2005;41:553–8.

    Article  CAS  Google Scholar 

  34. Bevers EM, Comfurius P, Zwaal RF. Platelet procoagulant activity: physiological significance and mechanisms of exposure. Blood Rev. 1991;5:146–54.

    Article  CAS  Google Scholar 

  35. Tripodi A, Primignani M, Chantarangkul V, et al. Thrombin generation in patients with cirrhosis: the role of platelets. Hepatology. 2006;44:440–5.

    Article  CAS  Google Scholar 

  36. Wong F. The use of TIPS in chronic liver disease. Ann Hepatol. 2006;5:5–15.

    Article  Google Scholar 

  37. Jabbour N, Zajko A, Orons P, Irish W, Fung JJ, Selby RR. Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis? Dig Dis Sci. 1998;43:2459–62.

    Article  CAS  Google Scholar 

  38. Ramsey G. Treating coagulopathy in liver disease with plasma transfusions or recombinant factor VIIa: an evidence-based review. Best Pract Res Clin Haematol. 2006;19(1):113–26.

    Article  CAS  Google Scholar 

  39. Bosch J, Thabut D, Bendtsen F, et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology. 2004;127:1123–30.

    Article  CAS  Google Scholar 

  40. Shami VM, Caldwell SH, Hespenheide EE, et al. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transpl. 2003;9:138–43.

    Article  Google Scholar 

  41. Argo CK, Balogun RA. Blood products, volume control, and renal support in the coagulopathy of liver disease. Clin Liver Dis. 2009;13:73–85.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India

    Rakhee Kar

Authors
  1. Rakhee Kar
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Hematology, All India Institute of Medical Sciences, New Delhi, India

    Renu Saxena

  2. Department of Hematology, All India Institute of Medical Sciences, New Delhi, India

    Hara Prasad Pati

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kar, R. (2019). Hepatic Coagulopathy: Intricacies and Challenges. In: Saxena, R., Pati, H. (eds) Hematopathology. Springer, Singapore. https://doi.org/10.1007/978-981-13-7713-6_19

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-7713-6_19

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-7712-9

  • Online ISBN: 978-981-13-7713-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation